Cargando…

Testosterone replacement in the infertile man

Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man’s health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Majzoub, Ahmad, Sabanegh, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182223/
https://www.ncbi.nlm.nih.gov/pubmed/28078217
http://dx.doi.org/10.21037/tau.2016.08.03
_version_ 1782485827198124032
author Majzoub, Ahmad
Sabanegh, Edmund
author_facet Majzoub, Ahmad
Sabanegh, Edmund
author_sort Majzoub, Ahmad
collection PubMed
description Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man’s health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism treatment. Despite that, patients complaining of infertility or seeking conception are still hindered by the unfavorable effects supplemental T has on testicular function. Consequently, alternative approaches that can stimulate endogenous T production are favored. Selective estrogen receptor modulators, gonadotropins and aromatase inhibitors (AIs) can be successful in restoring serum T levels, preserving fertility, and providing symptomatic relief.
format Online
Article
Text
id pubmed-5182223
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-51822232017-01-11 Testosterone replacement in the infertile man Majzoub, Ahmad Sabanegh, Edmund Transl Androl Urol Review Article Hypogonadism is a common clinical condition affecting men of different age groups. In addition to its sexual consequences, it has several implications posing significant concerns for a man’s health and well-being. Recent advances in testosterone (T) supplementation have facilitated hypogonadism treatment. Despite that, patients complaining of infertility or seeking conception are still hindered by the unfavorable effects supplemental T has on testicular function. Consequently, alternative approaches that can stimulate endogenous T production are favored. Selective estrogen receptor modulators, gonadotropins and aromatase inhibitors (AIs) can be successful in restoring serum T levels, preserving fertility, and providing symptomatic relief. AME Publishing Company 2016-12 /pmc/articles/PMC5182223/ /pubmed/28078217 http://dx.doi.org/10.21037/tau.2016.08.03 Text en 2016 Translational Andrology and Urology. All rights reserved.
spellingShingle Review Article
Majzoub, Ahmad
Sabanegh, Edmund
Testosterone replacement in the infertile man
title Testosterone replacement in the infertile man
title_full Testosterone replacement in the infertile man
title_fullStr Testosterone replacement in the infertile man
title_full_unstemmed Testosterone replacement in the infertile man
title_short Testosterone replacement in the infertile man
title_sort testosterone replacement in the infertile man
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182223/
https://www.ncbi.nlm.nih.gov/pubmed/28078217
http://dx.doi.org/10.21037/tau.2016.08.03
work_keys_str_mv AT majzoubahmad testosteronereplacementintheinfertileman
AT sabaneghedmund testosteronereplacementintheinfertileman